{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:51:19Z","timestamp":1781628679589,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T00:00:00Z","timestamp":1411603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1472-6947-14-86","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T15:01:34Z","timestamp":1411657294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Variability of the impact of adverse events on physicians\u2019 decision making"],"prefix":"10.1186","volume":"14","author":[{"given":"Raluca","family":"Cozmuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Fraenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"key":"848_CR1","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1001\/jama.2013.7100","volume":"309","author":"A Kachalia","year":"2013","unstructured":"Kachalia A, Mello MM: Breast cancer screening: conflicting guidelines and medicolegal risk. JAMA. 2013, 309: 2555-2556. 10.1001\/jama.2013.7100.","journal-title":"JAMA"},{"key":"848_CR2","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"GRADE Working Group","year":"2004","unstructured":"GRADE Working Group: Grading quality of evidence and strength of recommendations. BMJ. 2004, 328: 1490-1497.","journal-title":"BMJ"},{"key":"848_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CGM, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, for the RAVE-ITN Research Group: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010, 363: 221-232. 10.1056\/NEJMoa0909905.","journal-title":"N Engl J Med"},{"key":"848_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB, Tervaert JWC, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh D, Walsh M, Westman K, Jayne DRW, for\u00a0the European Vasculitis Study Group: Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010, 363: 211-220. 10.1056\/NEJMoa0909169.","journal-title":"N Engl J Med"},{"key":"848_CR5","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1002\/art.20592","volume":"50","author":"JH Anolik","year":"2004","unstructured":"Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I: Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum. 2004, 50: 3580-3590. 10.1002\/art.20592.","journal-title":"Arthritis Rheum"},{"key":"848_CR6","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/art.10466","volume":"46","author":"JE Balow","year":"2002","unstructured":"Balow JE: Choosing treatment for proliferative lupus nephritis. Arthritis Rheum. 2002, 46: 1981-1983. 10.1002\/art.10466.","journal-title":"Arthritis Rheum"},{"key":"848_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2007.11.013","volume":"30","author":"EJ Boren","year":"2008","unstructured":"Boren EJ, Cheema GS, Naguwa SM, Ansari AA, Gershwin ME: The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun. 2008, 30: 90-98. 10.1016\/j.jaut.2007.11.013.","journal-title":"J Autoimmun"},{"key":"848_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","volume":"340","author":"DT Boumpas","year":"1992","unstructured":"Boumpas DT, Austin HA, Balow JE, Vaughan EM, Yarboro CH, Klippel JH, Steinberg AD: Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet. 1992, 340: 741-745. 10.1016\/0140-6736(92)92292-N.","journal-title":"Lancet"},{"key":"848_CR9","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.22679","volume":"57","author":"P Cohen","year":"2007","unstructured":"Cohen P, Pagnoux C, Mahr A, Ar\u00e8ne JP, Mouthon L, Le Guern V, Andr\u00e9 MH, Gayraud M, Jayne D, Bl\u00f6ckmans D, Cordier JF, Guillevin L, French Vasculitis Study Group: Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum. 2007, 57: 686-693. 10.1002\/art.22679.","journal-title":"Arthritis Rheum"},{"key":"848_CR10","doi-asserted-by":"publisher","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","volume":"150","author":"K De Groot","year":"2009","unstructured":"De Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO, EUVAS (European Vasculitis Study Group): Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Intern Med. 2009, 150: 670-680. 10.7326\/0003-4819-150-10-200905190-00004.","journal-title":"Ann Intern Med"},{"key":"848_CR11","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"K De Groot","year":"2005","unstructured":"De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR: Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005, 52: 2461-2469. 10.1002\/art.21142.","journal-title":"Arthritis Rheum"},{"key":"848_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","volume":"98","author":"AS Fauci","year":"1983","unstructured":"Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener\u2019s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21\u00a0years. Ann Internal Med. 1983, 98: 76-85. 10.7326\/0003-4819-98-1-76.","journal-title":"Ann Internal Med"},{"key":"848_CR13","first-page":"100","volume":"35","author":"M Faurschou","year":"2008","unstructured":"Faurschou M, Sorensen IJ, Mellemkjaer L, Loft AG, Thomsen BS, Tvede N, Baslund B: Malignancies in Wegener\u2019s granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol. 2008, 35: 100-105.","journal-title":"J Rheumatol"},{"key":"848_CR14","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa043731","volume":"53","author":"EM Ginzler","year":"2005","unstructured":"Ginzler EM, Dooley MA, Aranow C, Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB: Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med. 2005, 53: 2219-2228.","journal-title":"N Engl J Med"},{"key":"848_CR15","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/art.22505","volume":"56","author":"I Gunnarsson","year":"2007","unstructured":"Gunnarsson I, Sundelin B, Jonsdottir T, Jacobson SH, Henriksson EW, van Vollenhoven RF: Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis. Arthritis Rheum. 2007, 56: 1263-1272. 10.1002\/art.22505.","journal-title":"Arthritis Rheum"},{"key":"848_CR16","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"FA Houssiau","year":"2002","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, G\u00fcl A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R: Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002, 46: 2121-2131. 10.1002\/art.10461.","journal-title":"Arthritis Rheum"},{"key":"848_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1440-1797.2009.01101.x","volume":"14","author":"D Jayne","year":"2009","unstructured":"Jayne D: Review article: progress of treatment in ANCA-associated vasculitis. Nephrology. 2009, 14: 42-48. 10.1111\/j.1440-1797.2009.01101.x.","journal-title":"Nephrology"},{"key":"848_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0025-6196(11)63594-5","volume":"72","author":"DR Jayne","year":"1997","unstructured":"Jayne DR, Rasmussen N: Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European community systemic vasculitis clinical trials study group. Mayo Clin Proc. 1997, 72: 737-747. 10.1016\/S0025-6196(11)63594-5.","journal-title":"Mayo Clin Proc"},{"key":"848_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/art.27233","volume":"62","author":"JT Merrill","year":"2010","unstructured":"Merrill JT, Neuwelt CM, Wallace DJ, Shanahan JC, Latinis KM, Oates JC, Utset TO, Gordon C, Isenberg DA, Hsieh HJ, Zhang D, Brunetta PG: Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010, 62: 222-233. 10.1002\/art.27233.","journal-title":"Arthritis Rheum"},{"key":"848_CR20","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/art.10138","volume":"46","author":"CC Mok","year":"2002","unstructured":"Mok CC, Ho CTK, Chan KW, Lau CS, Wong RWS: Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum. 2002, 46: 1003-1013. 10.1002\/art.10138.","journal-title":"Arthritis Rheum"},{"key":"848_CR21","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/ard.2007.071936","volume":"67","author":"C Mukhtyar","year":"2008","unstructured":"Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA, European Vasculitis Study Group (EUVAS): Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European league against rheumatism systemic vasculitis task force. Ann Rheum Dis. 2008, 67: 1004-1010. 10.1136\/ard.2007.071936.","journal-title":"Ann Rheum Dis"},{"key":"848_CR22","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/art.1780380815","volume":"38","author":"CD Radis","year":"1995","unstructured":"Radis CD, Kahl LE, Baker GL, Wasko MC, Cash JM, Gallatin A, Stolzer BL, Agarwal AK, Medsger TA, Kwoh CK: Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis a 20-year followup study. Arthritis Rheum. 1995, 38: 1120-1127. 10.1002\/art.1780380815.","journal-title":"Arthritis Rheum"},{"key":"848_CR23","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/art.21263","volume":"52","author":"EC Somers","year":"2005","unstructured":"Somers EC, Marder W, Christman GM, Ognenovski V, McCune WJ: Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum. 2005, 52: 2761-2767. 10.1002\/art.21263.","journal-title":"Arthritis Rheum"},{"key":"848_CR24","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/rheumatology\/kel098","volume":"45","author":"R Stasi","year":"2006","unstructured":"Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D: Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology. 2006, 45: 1432-1436. 10.1093\/rheumatology\/kel098.","journal-title":"Rheumatology"},{"key":"848_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","volume":"124","author":"C Talar-Williams","year":"1996","unstructured":"Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, Kerr GS, Hoffman GS, Fauci AS, Sneller MC: Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener Granulomatosis. Ann Intern Med. 1996, 124: 477-484. 10.7326\/0003-4819-124-5-199603010-00003.","journal-title":"Ann Intern Med"},{"key":"848_CR26","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/rheumatology\/ken071","volume":"47","author":"Y Tamimoto","year":"2008","unstructured":"Tamimoto Y, Horiuchi T, Tsukamoto H, Otsuka J, Mitoma H, Kimoto Y, Nakashima H, Muta K, Abe Y, Kiyohara C, Ueda A, Nagasawa K, Yoshizawa S, Shimoda T, Harada M: A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans\u2019 syndrome: immunological analysis of B cells, T cells and cytokines. Rheumatology. 2008, 47: 821-827. 10.1093\/rheumatology\/ken071.","journal-title":"Rheumatology"},{"key":"848_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/0022022104264126","volume":"35","author":"H van Herk","year":"2004","unstructured":"van Herk H, Poortinga YH, Verhallen TMM: Response styles in rating scales. J Cross Cult Psychol. 2004, 35: 346-360. 10.1177\/0022022104264126.","journal-title":"J Cross Cult Psychol"},{"key":"848_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jhealeco.2006.04.002","volume":"26","author":"T Flynn","year":"2007","unstructured":"Flynn T, Louviere J, Peters T, Coast J: Best-worst scaling: what it can do for health care research and how to do it. J Health Econ. 2007, 26: 171-189. 10.1016\/j.jhealeco.2006.04.002.","journal-title":"J Health Econ"},{"key":"848_CR29","unstructured":"The MaxDiff\/Web v6.0 Technical Paper:http:\/\/www.sawtoothsoftware.com\/download\/techpap\/maxdifftech.pdf,"},{"key":"848_CR30","volume-title":"Hierarchical Bayes regression analysis: technical paper","author":"B Orme","year":"2003","unstructured":"Orme B: Hierarchical Bayes regression analysis: technical paper. 2003, Sequim: Sawtooth Software, Available from: http:\/\/www.sawtoothsoftware.com"},{"key":"848_CR31","volume-title":"Rituximab (marketed as Rituxan): Progressive Multifocal Leukoencephalopathy (PML)","author":"Post Marketing Reviews","year":"2007","unstructured":"Post Marketing Reviews: Rituximab (marketed as Rituxan): Progressive Multifocal Leukoencephalopathy (PML). 2007, Available from: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/DrugSafetyNewsletter\/ucm115974.htm"},{"key":"848_CR32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/acr.21564","volume":"64","author":"A Bharat","year":"2012","unstructured":"Bharat A, Xie F, Baddley JW, Beukelman T, Chen L, Calabrese L, Delzell E, Grijalva CG, Patkar NM, Saag K, Winthrop KL, Curtis JR: Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases. Arthritis Care Res. 2012, 64: 612-615. 10.1002\/acr.21564.","journal-title":"Arthritis Care Res"},{"issue":"Suppl 2","key":"848_CR33","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.3949\/ccjm.78.s2.07","volume":"78","author":"ES Molloy","year":"2011","unstructured":"Molloy ES: PML and rheumatology: the contribution of disease and drugs. Clevel Clin J Med. 2011, 78 (Suppl 2): S28-S32.","journal-title":"Clevel Clin J Med"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-14-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6947-14-86\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-14-86","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-14-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:04:35Z","timestamp":1630562675000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/1472-6947-14-86"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["848"],"URL":"https:\/\/doi.org\/10.1186\/1472-6947-14-86","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,25]]},"assertion":[{"value":"17 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"86"}}